FDAnews Drug Daily Bulletin

IMAGENETIX LICENSES PATENT RELATED TO BODY FAT CONTROL

Nov. 18, 2005
A A

Imagenetix, Inc. (IAGX), an innovator of scientifically tested, natural-based, proprietary bioceutical products that enhance human health, today announced it has signed a license agreement with the University of Minnesota for the exclusive rights to the University's recently awarded patent covering a natural compound for lowering the body's levels of leptin, a circulating hormone that regulates fat storage. The compound, branded as Lepitrim(TM), will be marketed immediately by Imagenetix and its distribution partners across the U.S. and Canada.

NPI Center (http://www.npicenter.com/anm/templates/newsATemp.aspx?articleid=14227&zoneid=9)